p.101 抽出テキスト

934. Egbe AC, Connolly HM, Pellikka PA, Schaff HV, Hanna R, Maleszewski JJ, et al. Outcomes of warfarin therapy for bioprosthetic valve thrombosis of surgically implanted valves: a prospective study. JACC Cardiovasc Interv 2017;10:379–87. https:// doi.org/10.1016/j.jcin.2016.11.027 935. Jose J, Sulimov DS, El-Mawardy M, Sato T, Allali A, Holy EW, et al. Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement: incidence, characteristics, and treatment outcomes. JACC Cardiovasc Interv 2017;10:686–97. https:// doi.org/10.1016/j.jcin.2017.01.045 936. Petrescu I, Egbe AC, Ionescu F, Nkomo VT, Greason KL, Pislaru C, et al. Long-term outcomes of anticoagulation for bioprosthetic valve thrombosis. J Am Coll Cardiol 2020;75:857–66. https://doi.org/10.1016/j.jacc.2019.12.037 937. Pislaru SV, Hussain I, Pellikka PA, Maleszewski JJ, Hanna RD, Schaff HV, et al. Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series. Eur J Cardiothorac Surg 2015;47: 725–32. https://doi.org/10.1093/ejcts/ezu201 938. Puri R, Auffret V, Rodés-Cabau J. Bioprosthetic valve thrombosis. J Am Coll Cardiol 2017;69:2193–211. https://doi.org/10.1016/j.jacc.2017.02.051 939. Sellers SL, Turner CT, Sathananthan J, Cartlidge TRG, Sin F, Bouchareb R, et al. Transcatheter aortic heart valves: histological analysis providing insight to leaflet thickening and structural valve degeneration. JACC Cardiovasc Imaging 2019;12:135–45. https://doi.org/10.1016/j.jcmg.2018.06.028 940. Alkhouli M, Rihal CS, Zack CJ, Eleid MF, Maor E, Sarraf M, et al. Transcatheter and surgical management of mitral paravalvular leak: long-term outcomes. JACC Cardiovasc Interv 2017;10:1946–56. https://doi.org/10.1016/j.jcin.2017.07.046 941. Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 2014;312:162–70. https://doi.org/10.1001/jama.2014.7246 942. Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J 2019;40:441–51. https://doi. org/10.1093/eurheartj/ehy590 943. Whisenant B, Kapadia SR, Eleid MF, Kodali SK, McCabe JM, Krishnaswamy A, et al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol 2020;5:1245–52. https://doi.org/10.1001/jamacardio.2020.2974 944. McElhinney DB, Aboulhosn JA, Dvir D, Whisenant B, Zhang Y, Eicken A, et al. Mid-term valve-related outcomes after transcatheter tricuspid valve-in-valve or valve-in-ring replacement. J Am Coll Cardiol 2019;73:148–57. https://doi.org/10.1016/ j.jacc.2018.10.051 945. Muratori M, Montorsi P, Teruzzi G, Celeste F, Doria E, Alamanni F, et al. Feasibility and diagnostic accuracy of quantitative assessment of mechanical prostheses leaflet motion by transthoracic and transesophageal echocardiography in suspected prosthetic valve dysfunction. Am J Cardiol 2006;97:94–100. https://doi.org/10.1016/j.amjcard.2005.07. 112 946. Barbetseas J, Nagueh SF, Pitsavos C, Toutouzas PK, Quiñones MA, Zoghbi WA. Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters. J Am Coll Cardiol 1998;32:1410–7. https://doi.org/10.1016/s0735- 1097(98)00385-4 947. Suchá D, Symersky P, Vonken EJPA, Provoost E, Chamuleau SA, Budde RP. Multidetector-row computed tomography allows accurate measurement of mechanical prosthetic heart valve leaflet closing angles compared with fluoroscopy. J Comput Assist Tomogr 2014;38:451–6. https://doi.org/10.1097/RCT.0b013e3182ab5f15 948. Daniel WG, Mügge A, Grote J, Hausmann D, Nikutta P, Laas J, et al. Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am J Cardiol 1993;71:210–5. https://doi.org/10.1016/0002-9149(93)90740-4 949. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, et al. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with lowdose, slow infusion of tissue-type plasminogen activator. Circulation 2013;128:532–40. https://doi.org/10.1161/circulationaha.113.001145 950. Taherkhani M, Hashemi SR, Hekmat M, Safi M, Taherkhani A, Movahed MR. Thrombolytic therapy for right-sided mechanical pulmonic and tricuspid valves: the largest survival analysis to date. Tex Heart Inst J 2015;42:543–7. https://doi.org/10.14503/ THIJ-14-4659 951. Roudaut R, Roques X, Lafitte S, Choukroun E, Laborde N, Madona F, et al. Surgery for prosthetic valve obstruction. A single center study of 136 patients. Eur J Cardiothorac Surg 2003;24:868–72. https://doi.org/10.1016/s1010-7940(03)00568-2 952. Nishanth KR, Shankar M, Srinivasa KH, Manjunath CN, Ravindranath KS. Fibrinolysis in left-sided mechanical prosthetic valve thrombosis with high INR. Eur Heart J Acute Cardiovasc Care 2020;9:S58–62. https://doi.org/10.1177/2048872619846329 953. Separham A, Ghaffari S, Aslanabadi N, Sohrabi B, Ghojazadeh M, Anamzadeh E, et al. Prosthetic valve thrombosis. J Card Surg 2015;30:246–50. https://doi.org/10.1111/jocs. 12510 954. Farzaneh K, Mortazavi SH, Oraii A, Abbasi K, Salehi Omran A, Ahmadi Tafti SH, et al. Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels. J Card Surg 2020;35:2522–8. https://doi. org/10.1111/jocs.14777 955. Jander N, Kienzle RP, Kayser G, Neumann FJ, Gohlke-Baerwolf C, Minners J. Usefulness of phenprocoumon for the treatment of obstructing thrombus in bioprostheses in the aortic valve position. Am J Cardiol 2012;109:257–62. https://doi. org/10.1016/j.amjcard.2011.08.038 956. Oliver JM, Gallego P, Gonzalez A, Dominguez FJ, Gamallo C, Mesa JM. Bioprosthetic mitral valve thrombosis: clinical profile, transesophageal echocardiographic features, and follow-up after anticoagulant therapy. J Am Soc Echocardiogr 1996;9:691–9. https://doi.org/10.1016/s0894-7317(96)90066-8 957. Agarwal S, Rajamanickam A, Bajaj NS, Griffin BP, Catacutan T, Svensson LG, et al. Impact of aortic stenosis on postoperative outcomes after noncardiac surgeries. Circ Cardiovasc Qual Outcomes 2013;6:193–200. https://doi.org/10.1161/CIRC OUTCOMES.111.000091 958. Taniguchi T, Morimoto T, Shiomi H, Ando K, Shirai S, Kanamori N, et al. Elective noncardiac surgery in patients with severe aortic stenosis — observations from the CURRENT AS registry. Circ J 2020;84:1173–82. https://doi.org/10.1253/circj.CJ-20- 0026 959. Luis SA, Dohaei A, Chandrashekar P, Scott CG, Padang R, Lokineni S, et al. Impact of aortic valve replacement for severe aortic stenosis on perioperative outcomes following major noncardiac surgery. Mayo Clin Proc 2020;95:727–37. https://doi.org/10.1016/ j.mayocp.2019.10.038 960. Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery. Eur Heart J 2022;43:3826–924. https://doi.org/10.1093/eurheartj/ ehac270 961. Okuno T, Demirel C, Tomii D, Erdoes G, Heg D, Lanz J, et al. Risk and timing of noncardiac surgery after transcatheter aortic valve implantation. JAMA Netw Open 2022;5: e2220689. https://doi.org/10.1001/jamanetworkopen.2022.20689 962. Tashiro T, Pislaru SV, Blustin JM, Nkomo VT, Abel MD, Scott CG, et al. Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice. Eur Heart J 2014;35:2372–81. https://doi.org/10.1093/ eurheartj/ehu044 963. Okuno T, Yahagi K, Horiuchi Y, Sato Y, Tanaka T, Koseki K, et al. The role of transcatheter aortic valve replacement in the patients with severe aortic stenosis requiring major non-cardiac surgery. Cardiovasc Interv Ther 2019;34:345–51. https://doi.org/10. 1007/s12928-019-00575-z 964. Calleja AM, Dommaraju S, Gaddam R, Cha S, Khandheria BK, Chaliki HP. Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 2010;105:1159–63. https://doi.org/10.1016/j.amjcard. 2009.12.019 965. Sohrabi B, Kazemi B, Mehryar A, Teimouri-Dereshki A, Toufan M, Aslanabadi N. Correlation between pulmonary artery pressure measured by echocardiography and right heart catheterization in patients with rheumatic mitral valve stenosis (a prospective study). Echocardiography 2016;33:7–13. https://doi.org/10.1111/echo.13000 966. Smilowitz NR, Armanious A, Bangalore S, Ramakrishna H, Berger JS. Cardiovascular outcomes of patients with pulmonary hypertension undergoing noncardiac surgery. Am J Cardiol 2019;123:1532–7. https://doi.org/10.1016/j.amjcard.2019.02.006 967. Bajaj NS, Agarwal S, Rajamanickam A, Parashar A, Poddar KL, Griffin BP, et al. Impact of severe mitral regurgitation on postoperative outcomes after noncardiac surgery. Am J Med 2013;126:529–35. https://doi.org/10.1016/j.amjmed.2012.12.005 968. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165–241. https://doi.org/10.1093/ eurheartj/ehy340 969. Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J 2019;40: 3848–55. https://doi.org/10.1093/eurheartj/ehz136 970. Pande SN, Yavana Suriya J, Ganapathy S, Pillai AA, Satheesh S, Mondal N, et al. Validation of risk stratification for cardiac events in pregnant women with valvular heart disease. J Am Coll Cardiol 2023;82:1395–406. https://doi.org/10.1016/j.jacc. 2023.07.023 971. van Hagen IM, Thorne SA, Taha N, Youssef G, Elnagar A, Gabriel H, et al. Pregnancy outcomes in women with rheumatic mitral valve disease: results from the Registry of Pregnancy and Cardiac Disease. Circulation 2018;137:806–16. https://doi.org/10.1161/ CIRCULATIONAHA.117.032561 972. Orwat S, Diller GP, van Hagen IM, Schmidt R, Tobler D, Greutmann M, et al. Risk of pregnancy in moderate and severe aortic stenosis: from the multinational ROPAC registry. J Am Coll Cardiol 2016;68:1727–37. https://doi.org/10.1016/j.jacc.2016.07.750 973. Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJ. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 2005;26:914–20. https://doi.org/10.1093/eurheartj/ehi103 974. McKellar SH, MacDonald RJ, Michelena HI, Connolly HM, Sundt TMI. Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single

ESC Guidelines                                                                                                                                                                                          4735

Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026